The genetics of smoking in individuals with chronic obstructive pulmonary disease

Ma'en Obeidat, Guohai Zhou, Xuan Li, Nadia Hansel, Nicholas Rafaels, Rasika Mathias, Ingo Ruczinski, Terri L Beaty, Kathleen C. Barnes, Peter D. Paré, Don D. Sin

Research output: Contribution to journalArticle

Abstract

Background: Smoking is the principal modifiable environmental risk factor for chronic obstructive pulmonary disease (COPD) which affects 300 million people and is the 3rd leading cause of death worldwide. Most of the genetic studies of smoking have relied on self-reported smoking status which is vulnerable to reporting and recall bias. Using data from the Lung Health Study (LHS), we sought to identify genetic variants associated with quantitative smoking and cessation in individuals with mild to moderate COPD. Methods: The LHS is a longitudinal multicenter study of mild-to-moderate COPD subjects who were all smokers at recruitment. We performed genome-wide association studies (GWASs) for salivary cotinine (n = 4024), exhaled carbon monoxide (eCO) (n = 2854), cigarettes per day (CPD) (n = 2706) and smoking cessation at year 5 follow-up (n = 717 quitters and 2175 smokers). The GWAS analyses were adjusted for age, gender, and genetic principal components. Results: For cotinine levels, SNPs near UGT2B10 gene achieved genome-wide significance (i.e. P < 5 × 10- 8) with top SNP rs10023464, P = 1.27 × 10- 11. For eCO levels, one significant SNP was identified which mapped to the CHRNA3 gene (rs12914385, P = 2.38 × 10- 8). A borderline region mapping to KCNMA1 gene was associated with smoking cessation (rs207675, P = 5.95 × 10- 8). Of the identified loci, only the CHRNA3/5 locus showed significant associations with lung function but only in heavy smokers. No regions met genome-wide significance for CPD. Conclusion: The study demonstrates that using objective measures of smoking such as eCO and/or salivary cotinine can more precisely capture the genetic contribution to multiple aspects of smoking behaviour. The KCNMA1 gene association with smoking cessation may represent a potential therapeutic target and warrants further studies.

Original languageEnglish (US)
Article number59
JournalRespiratory Research
Volume19
Issue number1
DOIs
StatePublished - Apr 10 2018

Fingerprint

Chronic Obstructive Pulmonary Disease
Smoking Cessation
Cotinine
Smoking
Genome-Wide Association Study
Carbon Monoxide
Single Nucleotide Polymorphism
Tobacco Products
Lung
Genes
Genome
Health
Multicenter Studies
Longitudinal Studies
Cause of Death
Therapeutics

Keywords

  • Cessation
  • Cotinine
  • ECO
  • GWAS
  • Smoking

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

The genetics of smoking in individuals with chronic obstructive pulmonary disease. / Obeidat, Ma'en; Zhou, Guohai; Li, Xuan; Hansel, Nadia; Rafaels, Nicholas; Mathias, Rasika; Ruczinski, Ingo; Beaty, Terri L; Barnes, Kathleen C.; Paré, Peter D.; Sin, Don D.

In: Respiratory Research, Vol. 19, No. 1, 59, 10.04.2018.

Research output: Contribution to journalArticle

Obeidat, Ma'en ; Zhou, Guohai ; Li, Xuan ; Hansel, Nadia ; Rafaels, Nicholas ; Mathias, Rasika ; Ruczinski, Ingo ; Beaty, Terri L ; Barnes, Kathleen C. ; Paré, Peter D. ; Sin, Don D. / The genetics of smoking in individuals with chronic obstructive pulmonary disease. In: Respiratory Research. 2018 ; Vol. 19, No. 1.
@article{0e811fbc1a3d4a9fbe7eff2acf70615c,
title = "The genetics of smoking in individuals with chronic obstructive pulmonary disease",
abstract = "Background: Smoking is the principal modifiable environmental risk factor for chronic obstructive pulmonary disease (COPD) which affects 300 million people and is the 3rd leading cause of death worldwide. Most of the genetic studies of smoking have relied on self-reported smoking status which is vulnerable to reporting and recall bias. Using data from the Lung Health Study (LHS), we sought to identify genetic variants associated with quantitative smoking and cessation in individuals with mild to moderate COPD. Methods: The LHS is a longitudinal multicenter study of mild-to-moderate COPD subjects who were all smokers at recruitment. We performed genome-wide association studies (GWASs) for salivary cotinine (n = 4024), exhaled carbon monoxide (eCO) (n = 2854), cigarettes per day (CPD) (n = 2706) and smoking cessation at year 5 follow-up (n = 717 quitters and 2175 smokers). The GWAS analyses were adjusted for age, gender, and genetic principal components. Results: For cotinine levels, SNPs near UGT2B10 gene achieved genome-wide significance (i.e. P < 5 × 10- 8) with top SNP rs10023464, P = 1.27 × 10- 11. For eCO levels, one significant SNP was identified which mapped to the CHRNA3 gene (rs12914385, P = 2.38 × 10- 8). A borderline region mapping to KCNMA1 gene was associated with smoking cessation (rs207675, P = 5.95 × 10- 8). Of the identified loci, only the CHRNA3/5 locus showed significant associations with lung function but only in heavy smokers. No regions met genome-wide significance for CPD. Conclusion: The study demonstrates that using objective measures of smoking such as eCO and/or salivary cotinine can more precisely capture the genetic contribution to multiple aspects of smoking behaviour. The KCNMA1 gene association with smoking cessation may represent a potential therapeutic target and warrants further studies.",
keywords = "Cessation, Cotinine, ECO, GWAS, Smoking",
author = "Ma'en Obeidat and Guohai Zhou and Xuan Li and Nadia Hansel and Nicholas Rafaels and Rasika Mathias and Ingo Ruczinski and Beaty, {Terri L} and Barnes, {Kathleen C.} and Par{\'e}, {Peter D.} and Sin, {Don D.}",
year = "2018",
month = "4",
day = "10",
doi = "10.1186/s12931-018-0762-7",
language = "English (US)",
volume = "19",
journal = "Respiratory Research",
issn = "1465-9921",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The genetics of smoking in individuals with chronic obstructive pulmonary disease

AU - Obeidat, Ma'en

AU - Zhou, Guohai

AU - Li, Xuan

AU - Hansel, Nadia

AU - Rafaels, Nicholas

AU - Mathias, Rasika

AU - Ruczinski, Ingo

AU - Beaty, Terri L

AU - Barnes, Kathleen C.

AU - Paré, Peter D.

AU - Sin, Don D.

PY - 2018/4/10

Y1 - 2018/4/10

N2 - Background: Smoking is the principal modifiable environmental risk factor for chronic obstructive pulmonary disease (COPD) which affects 300 million people and is the 3rd leading cause of death worldwide. Most of the genetic studies of smoking have relied on self-reported smoking status which is vulnerable to reporting and recall bias. Using data from the Lung Health Study (LHS), we sought to identify genetic variants associated with quantitative smoking and cessation in individuals with mild to moderate COPD. Methods: The LHS is a longitudinal multicenter study of mild-to-moderate COPD subjects who were all smokers at recruitment. We performed genome-wide association studies (GWASs) for salivary cotinine (n = 4024), exhaled carbon monoxide (eCO) (n = 2854), cigarettes per day (CPD) (n = 2706) and smoking cessation at year 5 follow-up (n = 717 quitters and 2175 smokers). The GWAS analyses were adjusted for age, gender, and genetic principal components. Results: For cotinine levels, SNPs near UGT2B10 gene achieved genome-wide significance (i.e. P < 5 × 10- 8) with top SNP rs10023464, P = 1.27 × 10- 11. For eCO levels, one significant SNP was identified which mapped to the CHRNA3 gene (rs12914385, P = 2.38 × 10- 8). A borderline region mapping to KCNMA1 gene was associated with smoking cessation (rs207675, P = 5.95 × 10- 8). Of the identified loci, only the CHRNA3/5 locus showed significant associations with lung function but only in heavy smokers. No regions met genome-wide significance for CPD. Conclusion: The study demonstrates that using objective measures of smoking such as eCO and/or salivary cotinine can more precisely capture the genetic contribution to multiple aspects of smoking behaviour. The KCNMA1 gene association with smoking cessation may represent a potential therapeutic target and warrants further studies.

AB - Background: Smoking is the principal modifiable environmental risk factor for chronic obstructive pulmonary disease (COPD) which affects 300 million people and is the 3rd leading cause of death worldwide. Most of the genetic studies of smoking have relied on self-reported smoking status which is vulnerable to reporting and recall bias. Using data from the Lung Health Study (LHS), we sought to identify genetic variants associated with quantitative smoking and cessation in individuals with mild to moderate COPD. Methods: The LHS is a longitudinal multicenter study of mild-to-moderate COPD subjects who were all smokers at recruitment. We performed genome-wide association studies (GWASs) for salivary cotinine (n = 4024), exhaled carbon monoxide (eCO) (n = 2854), cigarettes per day (CPD) (n = 2706) and smoking cessation at year 5 follow-up (n = 717 quitters and 2175 smokers). The GWAS analyses were adjusted for age, gender, and genetic principal components. Results: For cotinine levels, SNPs near UGT2B10 gene achieved genome-wide significance (i.e. P < 5 × 10- 8) with top SNP rs10023464, P = 1.27 × 10- 11. For eCO levels, one significant SNP was identified which mapped to the CHRNA3 gene (rs12914385, P = 2.38 × 10- 8). A borderline region mapping to KCNMA1 gene was associated with smoking cessation (rs207675, P = 5.95 × 10- 8). Of the identified loci, only the CHRNA3/5 locus showed significant associations with lung function but only in heavy smokers. No regions met genome-wide significance for CPD. Conclusion: The study demonstrates that using objective measures of smoking such as eCO and/or salivary cotinine can more precisely capture the genetic contribution to multiple aspects of smoking behaviour. The KCNMA1 gene association with smoking cessation may represent a potential therapeutic target and warrants further studies.

KW - Cessation

KW - Cotinine

KW - ECO

KW - GWAS

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=85045212791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045212791&partnerID=8YFLogxK

U2 - 10.1186/s12931-018-0762-7

DO - 10.1186/s12931-018-0762-7

M3 - Article

C2 - 29631575

AN - SCOPUS:85045212791

VL - 19

JO - Respiratory Research

JF - Respiratory Research

SN - 1465-9921

IS - 1

M1 - 59

ER -